All Stories

  1. Solid Lipid Nanoparticles Containing Morin: Preparation, Characterization, and Ex Vivo Permeation Studies
  2. Bicalutamide Anticancer Activity Enhancement by Formulation of Soluble Inclusion Complexes with Cyclodextrins
  3. Chitosan/Cyclodextrin Nanospheres for Potential Nose-to-Brain Targeting of Idebenone
  4. In Situ Swelling Formulation of Glycerol-Monooleate-Derived Lyotropic Liquid Crystals Proposed for Local Vaginal Application
  5. A comparison between silicone‐free and silicone‐based emulsions: Technological features and in vivo evaluation
  6. Alginate-Based Composites for Corneal Regeneration: The Optimization of a Biomaterial to Overcome Its Limits
  7. Macrophage-Derived Extracellular Vesicles: A Promising Tool for Personalized Cancer Therapy
  8. Ammonium Glycyrrhizinate and Bergamot Essential Oil Co-Loaded Ultradeformable Nanocarriers: An Effective Natural Nanomedicine for In Vivo Anti-Inflammatory Topical Therapies
  9. Lyotropic Liquid Crystals: A Biocompatible and Safe Material for Local Cardiac Application
  10. Lipid-Based Formulations Containing Labrafil M2125-CS: A Deep Investigation on Nanosystem Stability
  11. Rutin-Loaded Nanovesicles for Improved Stability and Enhanced Topical Efficacy of Natural Compound
  12. Tendon Tissue Repair in Prospective of Drug Delivery, Regenerative Medicines, and Innovative Bioscaffolds
  13. Development of Chitosan/Cyclodextrin Nanospheres for Levofloxacin Ocular Delivery
  14. Positively Charged Lipid as Potential Tool to Influence the Fate of Ethosomes
  15. Radiopharmaceutical preparations: what are the legislative differences across Europe?
  16. Meglumine Antimoniate‐Loaded Aqueous‐Core PLA Nanocapsules: Old Drug, New Formulation against Leishmania ‐Related Diseases
  17. EtoGel for Intra-Articular Drug Delivery: A New Challenge for Joint Diseases Treatment
  18. Topical Unsaturated Fatty Acid Vesicles Improve Antioxidant Activity of Ammonium Glycyrrhizinate
  19. Nanonutraceuticals: The New Frontier of Supplementary Food
  20. Influence of Materials Properties on Bio-Physical Features and Effectiveness of 3D-Scaffolds for Periodontal Regeneration
  21. Rutin-Loaded Solid Lipid Nanoparticles: Characterization and In Vitro Evaluation
  22. Improvement of Ferulic Acid Antioxidant Activity by Multiple Emulsions: In Vitro and In Vivo Evaluation
  23. Oleuropein-Laded Ufasomes Improve the Nutraceutical Efficacy
  24. Targeting of the Pilosebaceous Follicle by Liquid Crystal Nanocarriers: In Vitro and In Vivo Effects of the Entrapped Minoxidil
  25. Design and Characterization of Glyceryl Monooleate-Nanostructures Containing Doxorubicin Hydrochloride
  26. Cardiac Stem Cell-Loaded Delivery Systems: A New Challenge for Myocardial Tissue Regeneration
  27. Vegetable-Milk-Based Yogurt-Like Structure: Rheological Properties Influenced by Gluten-Free Carob Seed Flour
  28. Ammonium glycyrrhizate skin delivery from ultradeformable liposomes: A novel use as an anti-inflammatory agent in topical drug delivery
  29. Influence of Various Model Compounds on the Rheological Properties of Zein-Based Gels
  30. Rutin-Loaded Poloxamer 407-Based Hydrogels for In Situ Administration: Stability Profiles and Rheological Properties
  31. The Rheolaser Master™ and Kinexus Rotational Rheometer® to Evaluate the Influence of Topical Drug Delivery Systems on Rheological Features of Topical Poloxamer Gel
  32. Poly(ethyl acrylate-co-methyl Methacrylate-co-trimethylammoniethyl methacrylate chloride) (Eudragit RS100) Nanocapsules as Nanovector Carriers for Phoenix dactylifera L. Seeds Oil: a Versatile Antidiabetic Agent
  33. Sulforaphane-Loaded Ultradeformable Vesicles as A Potential Natural Nanomedicine for the Treatment of Skin Cancer Diseases
  34. Development and In Vivo Evaluation of Multidrug Ultradeformable Vesicles for the Treatment of Skin Inflammation
  35. Physicochemical Characterization and Antioxidant Activity Evaluation of Idebenone/Hydroxypropyl-β-Cyclodextrin Inclusion Complex †
  36. Essential Oils-Loaded Polymer Particles: Preparation, Characterization and Antimicrobial Property
  37. Nanoformulation for potential topical delivery of Vismodegib in skin cancer treatment
  38. Polydocanol foam stabilized by liposomes: Supramolecular nanoconstructs for sclerotherapy
  39. Mathematical Models as Tools to Predict the Release Kinetic of Fluorescein from Lyotropic Colloidal Liquid Crystals
  40. Post-insertion parameters of PEG-derivatives in phosphocholine-liposomes
  41. Mathematical Models as Tools to Predict the Release Kinetic of Fluorescein from Monoglyceride Colloidal Liquid Crystals
  42. Simultaneous quantification of Gemcitabine and Irinotecan hydrochloride in rat plasma by using high performance liquid chromatography-diode array detector
  43. An insight of in vitro transport of PEGylated non-ionic surfactant vesicles (NSVs) across the intestinal polarized enterocyte monolayers
  44. Sodium deoxycholate-decorated zein nanoparticles for a stable colloidal drug delivery system
  45. Innovative vesicles for dermal and transdermal drug delivery
  46. Characterization and in vitro anticancer properties of chitosan-microencapsulated flavan-3-ols-rich grape seed extracts
  47. Physicochemical characterization of pH-responsive and fusogenic self-assembled non-phospholipid vesicles for a potential multiple targeting therapy
  48. Interaction between PEG lipid and DSPE/DSPC phospholipids: An insight of PEGylation degree and kinetics of de-PEGylation
  49. Oleuropein Decreases Cyclooxygenase-2 and Interleukin-17 Expression and Attenuates Inflammatory Damage in Colonic Samples from Ulcerative Colitis Patients
  50. Anticancer activity of all- trans retinoic acid-loaded liposomes on human thyroid carcinoma cells
  51. pH-sensitive niosomes: Effects on cytotoxicity and on inflammation and pain in murine models
  52. Drug delivery in overcoming the blood–brain barrier: role of nasal mucosal grafting
  53. Improvement of Oral Bioavailability of Curcumin upon Microencapsulation with Methacrylic Copolymers
  54. Rutin-loaded chitosan microspheres: Characterization and evaluation of the anti-inflammatory activity
  55. Pharmacological effect of a new idebenone formulation in a model of carrageenan-induced inflammatory pain
  56. Microextraction by packed sorbent and HPLC–PDA quantification of multiple anti-inflammatory drugs and fluoroquinolones in human plasma and urine
  57. Preparation, characterization and photostability assessment of curcumin microencapsulated within methacrylic copolymers
  58. PDE5 Inhibitors-Loaded Nanovesicles: Physico-Chemical Properties and In Vitro Antiproliferative Activity
  59. Nanotherapeutics for anti-inflammatory delivery
  60. Cationic Supramolecular Vesicular Aggregates for Pulmonary Tissue Selective Delivery in Anticancer Therapy
  61. Niosomes as Drug Nanovectors: Multiscale pH-Dependent Structural Response
  62. Helicobacter pylori ATCC 43629/NCTC 11639 Outer Membrane Vesicles (OMVs) from Biofilm and Planktonic Phase Associated with Extracellular DNA (eDNA)
  63. Delivery of miR-34a by chitosan/PLGA nanoplexes for the anticancer treatment of multiple myeloma
  64. Influence of the Supramolecular Micro-Assembly of Multiple Emulsions on their Biopharmaceutical Features and In vivo Therapeutic Response
  65. HPLC–FLD and spectrofluorometer apparatus: How to best detect fluorescent probe-loaded niosomes in biological samples
  66. Determination of ciprofloxacin and levofloxacin in human sputum collected from cystic fibrosis patients using microextraction by packed sorbent-high performance liquid chromatography photodiode array detector
  67. Ultradeformable liposomes as multidrug carrier of resveratrol and 5-fluorouracil for their topical delivery
  68. Polyethylene glycol (PEG)-dendron phospholipids as innovative constructs for the preparation of super stealth liposomes for anticancer therapy
  69. Bisphosphonate–polyaspartamide conjugates as bone targeted drug delivery systems
  70. Aqueous-core PEG-coated PLA nanocapsules for an efficient entrapment of water soluble anticancer drugs and a smart therapeutic response
  71. Polyaspartamide-Doxorubicin Conjugate as Potential Prodrug for Anticancer Therapy
  72. Targeting the thyroid gland with thyroid-stimulating hormone (TSH)-nanoliposomes
  73. Physicochemical features and transfection properties of chitosan/poloxamer 188/poly(D,L-lactide-co-glycolide) nanoplexes
  74. Evaluation of anticancer activity of celastrol liposomes in prostate cancer cells
  75. A characterization study of resveratrol/sulfobutyl ether-β-cyclodextrin inclusion complex and in vitro anticancer activity
  76. Niosomes from 80s to present: The state of the art
  77. Ammonium glycyrrhizinate-loaded niosomes as a potential nanotherapeutic system for anti-inflammatory activity in murine models
  78. Anticancer activity of liposomal bergamot essential oil (BEO) on human neuroblastoma cells
  79. Liposomal chemotherapeutics
  80. Sustained Zero-Order Release of Intact Ultra-Stable Drug-Loaded Liposomes from an Implantable Nanochannel Delivery System
  81. Differential Scanning Calorimetry as a Tool to Investigate the Transfer of Anticancer Drugs to Biomembrane Model
  82. Gemcitabine-loaded biocompatible nanocapsules for the effective treatment of human cancer
  83. Interaction of pH-sensitive non-phospholipid liposomes with cellular mimetic membranes
  84. Anti-inflammatory activity of novel ammonium glycyrrhizinate/niosomes delivery system: Human and murine models
  85. Squalenoyl prodrug of paclitaxel: Synthesis and evaluation of its incorporation in phospholipid bilayers
  86. Folate-targeted supramolecular vesicular aggregates as a new frontier for effective anticancer treatment in in vivo model
  87. Improved in vitro and in vivo collagen biosynthesis by asiaticoside-loaded ultradeformable vesicles
  88. In vitro antimycoplasmal activity of citrus bergamia essential oil and its major components
  89. Low-Frequency Ultrasound in Medicine: An In Vivo Evaluation
  90. Self-assembled squalenoyl-cytarabine nanostructures as a potent nanomedicine for treatment of leukemic diseases
  91. Paclitaxel-loaded ethosomes®: Potential treatment of squamous cell carcinoma, a malignant transformation of actinic keratoses
  92. Gemcitabine and tamoxifen-loaded liposomes as multidrug carriers for the treatment of breast cancer diseases
  93. Gemcitabine-loaded innovative nanocarriers vs GEMZAR: Biodistribution, pharmacokinetic features andin vivoantitumor activity
  94. Lipophilic Hydroxytyrosol Esters: Fatty Acid Conjugates for Potential Topical Administration
  95. Ethosomes® and transfersomes® containing linoleic acid: physicochemical and technological features of topical drug delivery carriers for the potential treatment of melasma disorders
  96. Gemcitabine-loaded chitosan microspheres. Characterization and biological in vitro evaluation
  97. Supramolecular devices to improve the treatment of brain diseases
  98. Liposomes as multicompartmental carriers for multidrug delivery in anticancer chemotherapy
  99. Drug Delivery Applications with Ethosomes
  100. Folate-targeted supramolecular vesicular aggregates based on polyaspartyl-hydrazide copolymers for the selective delivery of antitumoral drugs
  101. Non-ionic surfactant vesicles in pulmonary glucocorticoid delivery: Characterization and interaction with human lung fibroblasts
  102. In Vitro Evaluation of the Activity of Gemcitabine-Loaded Pegylated Unilamellar Liposomes Against Papillary Thyroid Cancer Cells~!2010-04-18~!2010-06-27~!2010-08-23~!
  103. Gemcitabine-loaded PEGylated unilamellar liposomes vs GEMZAR®: Biodistribution, pharmacokinetic features and in vivo antitumor activity
  104. Nanoparticulate devices for brain drug delivery
  105. A novel animal model to evaluate the ability of a drug delivery system to promote the passage through the BBB
  106. Turbiscan Lab® Expert analysis of the stability of ethosomes® and ultradeformable liposomes containing a bilayer fluidizing agent
  107. Novel PEG-coated niosomes based on bola-surfactant as drug carriers for 5-fluorouracil
  108. Retinoids: new use by innovative drug-delivery systems
  109. In vivo activity of gemcitabine-loaded PEGylated small unilamellar liposomes against pancreatic cancer
  110. Lipoamino Acid Prodrugs of Paclitaxel: Synthesis and Cytotoxicity Evaluation on Human Anaplastic Thyroid Carcinoma Cells
  111. Colloidal carriers for the enhanced delivery through the skin
  112. Liposomal delivery improves the growth-inhibitory and apoptotic activity of low doses of gemcitabine in multiple myeloma cancer cells
  113. Innovative bola-surfactant niosomes as topical delivery systems of 5-fluorouracil for the treatment of skin cancer
  114. Improved In Vitro Anti-Tumoral Activity, Intracellular Uptake and Apoptotic Induction of Gemcitabine-Loaded Pegylated Unilamellar Liposomes
  115. In vitro skin permeation of sunscreen agents from O/W emulsions
  116. Innovative Drug Delivery Systems for the Administration of Natural Compounds
  117. In vitro and in vivo evaluation of Bola-surfactant containing niosomes for transdermal delivery
  118. Effects of Lipid Composition and Preparation Conditions on Physical-Chemical Properties, Technological Parameters and In Vitro Biological Activity of Gemcitabine-Loaded Liposomes
  119. In vitro antimycoplasmal activity of Melaleuca alternifolia essential oil
  120. Influence of modified cyclodextrins on solubility and percutaneous absorption of celecoxib through human skin
  121. Electrocortical effects of MDMA are potentiated by acoustic stimulation in rats
  122. Physico-chemical characterization of disoxaril–dimethyl-β-cyclodextrin inclusion complex and in vitro permeation studies
  123. Combined NMR-crystallographic and modelling investigation of the inclusion of molsidomine into α-, β- and γ-cyclodextrins
  124. Ethosomes for skin delivery of ammonium glycyrrhizinate: In vitro percutaneous permeation through human skin and in vivo anti-inflammatory activity on human volunteers
  125. Preparation of celecoxib-dimethyl-β-cyclodextrin inclusion complex: characterization and in vitro permeation study
  126. Tolerability and improved protective action of idebenone‐loaded pegylated liposomes on ethanol‐induced injury in primary cortical astrocytes**Preliminary data were presented at the Second International Conference on New Biomedical Materials, 5–8 April ...
  127. Combining NMR and molecular modelling in a drug delivery context: investigation of the multi-mode inclusion of a new NPY-5 antagonist bromobenzenesulfonamide into β-cyclodextrin
  128. Synthesis, Characterization and In Vitro Evaluation of Dimethyl-β-cyclodextrin-4-biphenylylacetic Acid Conjugate
  129. Lecithin microemulsions for the topical administration of ketoprofen: percutaneous adsorption through human skin and in vivo human skin tolerability
  130. Ethanol-induced injury in rat primary cortical astrocytes involves oxidative stress: effect of idebenone
  131. Preparation, characterization, molecular modeling and In vitro activity of paclitaxel–cyclodextrin complexes
  132. In vitro and in vivo evaluation of caffeic and ferulic acids as topical photoprotective agents